Category: Providers

HRSA Again Selects Bizzell Group to Audit 340B Covered Entities

August 31, 2023 Tom Mirga, Editor at Large Views

Dr. Anton Bizzell is president and CEO of The Bizzell Group, which recently signed a contract with HRSA to continue auditing 340B covered entities.

The Health Resources and Services Administration (HRSA) has awarded a $25.3 million, five-year contract to The Bizzell Group to audit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Centers Fear Losing 340B Pricing From Sanofi at Multiple Contract Pharmacies

August 29, 2023 Tom Mirga, Editor at Large Views

Changes to Sanofi's 340B drug pricing conditions may eliminate 340B discounts for health centers using multiple contract pharmacies within a chain.

Recent apparent changes to 340B drug pricing conditions by drug manufacturer Sanofi may eliminate 340B discounts for health centers using [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lawmaker Sponsoring 340B Transparency Bill Honored by PhRMA-Provider Group

August 29, 2023 Rich Daly, Editor in Chief Views

Rep. Larry Bucshon (R-Indiana) received the "Saving America’s 340B Program Leadership Award" award from ASAP 340B.

The congressional sponsor of legislation that would require hospitals and potentially other covered entities to publicly report their 340B revenue, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Judge Accepts Drug Company Filings in 340B Patient Definition Case

August 29, 2023 Tom Mirga, Editor at Large Views

Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.

A federal district judge has allowed five major drugmakers to file friend-of-the-court briefs in a lawsuit over patient eligibility to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Center Leaders Urge Boards to Push State, Federal Support of 340B

August 29, 2023 Rich Daly, Editor in Chief Views

The National Association of Community Health Centers’ CHI and Expo addressed the advocacy role of health center boards of directors.

The boards of directors of health centers need to take on a bigger advocacy role in support of the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Center Asks Court to Reject Drug Maker Briefs in Challenge to 340B Patient Definition

August 24, 2023 William Newton, Associate Editor/Senior Writer Views

Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.

A health center challenging the government’s 340B program patient definition in a federal district court recently asked a federal judge [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHA Urges Dropping Bill Language to Exclude Generic Injectables from 340B

August 24, 2023 Rich Daly, Editor in Chief Views

AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

The nation’s largest hospital advocacy organization urged legislators to drop a provision from draft legislation that would exclude generic injectables [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Provider-PhRMA Coalition Adds Civil Rights Group

August 24, 2023 Rich Daly, Editor in Chief Views

ASAP 340B, a coalition of a drug industry trade group and a community health center organization, added a civil rights group to its membership.

An alliance led by a powerful drug industry trade group and community health center organization that is pushing for 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Maker Owes 340B Providers Repayment, HRSA Pending Audit Finds

August 22, 2023 Rich Daly, Editor in Chief Views

A HRSA fiscal year 2023 audit tentatively found that drug maker Nephron Pharmaceuticals owes 340B repayments to providers.

The first posted fiscal year 2023 audit of a drug maker tentatively found the company owes repayments to providers. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Drugs Among Those at Tornado-Hit Facility Requiring Direct Purchase

August 22, 2023 Rich Daly, Editor in Chief Views

Pfizer has limited multiple 340B-eligible drugs to direct purchase after a tornado damaged one of the drug maker's manufacturing facilities.

Federal officials confirmed that 340B-eligible drugs are among the 12 medications pharmaceutical manufacturer Pfizer has limited to direct purchase after [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live